Apixaban 5MG: Clinical Trials

6 trials of Apixaban 5MG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 1 terminated. 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Phase 33Unknown 2, Terminated 1

Follow Apixaban 5MG: new trials by email Literature Review of Apixaban 5MG trials Research Report on Apixaban 5MG

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers
Apixaban 5MG - Healthy Volunteer
Phase 1UnknownInternational Bio service282024-08-262024-05-24
PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg - Healthy
Phase 1CompletedHK inno.N Corporation872023-03-062023-12-11
Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects
Apixaban 5MG, Eliquis 5 mg - Antithrombic Drug
Phase 1CompletedHumanis Saglık Anonim Sirketi302023-02-232025-09-15
Dabigatran Versus Apixaban in Cerebral Venous Thrombosis
Dabigatran Etexilate 150mg, Apixaban 5MG - Cerebral Venous Sinus Thrombosis
Phase 3UnknownKafrelsheikh University2002021-08-012024-08-13
Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis
Apixaban 5MG, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Thrombosis
Phase 3UnknownKafrelsheikh University2002021-08-012024-08-19
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
Apixaban 2.5 MG, Apixaban 5MG, Aspirin - COVID-19
Phase 3TerminatedFrank C Sciurba6572020-09-072022-02-17

Conditions studied

Intracranial Thrombosis (2)  ·  COVID-19 (1)

Sponsors

Kafrelsheikh University (2)  ·  Frank C Sciurba (1)  ·  HK inno.N Corporation (1)  ·  Humanis Saglık Anonim Sirketi (1)  ·  International Bio service (1)

Countries

Egypt (2)  ·  India (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Frank Sciurba (1)  ·  Min-Gul Kim (1)  ·  Porranee Puranajoti, Ph. D (1)

Results publications

PMID 31867054, PMID 18190818, PMID 34473343, PMID 34633405, PMID 37189091, PMID 37489818, PMID 37591523